Edgewise Therapeutics, Inc.

The momentum for this stock is not very good. Edgewise Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Edgewise Therapeutics, Inc..

News

Head-To-Head Contrast: Edgewise Therapeutics (NASDAQ:EWTX) & Regeneron Pharmaceuticals (NASDAQ:REGN)

Zolmax Edgewise Therapeutics (NASDAQ:EWTX - Get Free Report) and Regeneron Pharmaceuticals (NASDAQ:REGN - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the...\n more…

Reviewing Edgewise Therapeutics (NASDAQ:EWTX) & Regeneron Pharmaceuticals (NASDAQ:REGN)

Ticker Report Edgewise Therapeutics (NASDAQ:EWTX - Get Free Report) and Regeneron Pharmaceuticals (NASDAQ:REGN - Get Free Report) are both medical companies, but which is the better investment? We will compare the...\n more…

Optimistic Buy Rating for Edgewise Therapeutics Amid Promising EDG-7500 Developments

TipRanks Financial Blog Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on EWTX stock, giving a Buy rating on August 16. Joseph Schwartz has g...\n more…

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Update

Zolmax Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totalling 8,080,000 shares...\n more…

Edgewise Therapeutics (NASDAQ:EWTX) Earns "Outperform" Rating from Wedbush

Ticker Report Wedbush reissued their outperform rating on shares of Edgewise Therapeutics (NASDAQ:EWTX - Free Report) in a research note published on Friday, Benzinga reports. They currently have a $31.00 price...\n more…

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.6%

Zolmax Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) shares traded down 3.6% during trading on Friday . The stock traded as low as $18.20 and last traded at $18.20. 218,817 shares changed...\n more…